Development of a targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry based lipidomics platform applied to a coronavirus disease severity study

[1]  L. Bindila,et al.  Four-dimensional trapped ion mobility spectrometry lipidomics for high throughput clinical profiling of human blood samples , 2023, Nature Communications.

[2]  Christina M. Jones,et al.  Omic-Scale High-Throughput Quantitative LC-MS/MS Approach for Circulatory Lipid Phenotyping in Clinical Research. , 2023, Analytical chemistry.

[3]  T. Hankemeier,et al.  Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress , 2022, Metabolites.

[4]  T. Hankemeier,et al.  Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers , 2022, Metabolites.

[5]  Daniel S Spellman,et al.  Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes , 2022, Journal of lipid research.

[6]  John A. Bowden,et al.  Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring , 2021, Analytical chemistry.

[7]  M. Clerici,et al.  Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature , 2021, International journal of molecular sciences.

[8]  John A. Bowden,et al.  Quality control requirements for the correct annotation of lipidomics data , 2021, Nature Communications.

[9]  A. Cazenave-Gassiot,et al.  LICAR: An Application for Isotopic Correction of Targeted Lipidomic Data Acquired with Class-Based Chromatographic Separations Using Multiple Reaction Monitoring. , 2021, Analytical chemistry.

[10]  Prof. Mohammed Abdalla Hussein,et al.  Plasma Phospholipids: A Promising Simple Biochemical Parameter to Evaluate COVID-19 Infection Severity , 2021, Bioinformatics and biology insights.

[11]  Garret A FitzGerald,et al.  Steps Toward Minimal Reporting Standards for Lipidomics Mass Spectrometry in Biomedical Research Publications , 2020, Circulation. Genomic and precision medicine.

[12]  Christer S. Ejsing,et al.  Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures , 2020, Journal of Lipid Research.

[13]  John A. Bowden,et al.  Nontargeted lipidomics of novel human plasma reference materials: hypertriglyceridemic, diabetic, and African-American , 2020, Analytical and Bioanalytical Chemistry.

[14]  R. Beger,et al.  Evaluation of the Performance of Lipidyzer Platform and its Application in the Lipidomics Analysis in Mouse Heart and Liver. , 2020, Journal of proteome research.

[15]  Gek Huey Chua,et al.  Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis , 2020, Cell Metabolism.

[16]  M. Abu-Farha,et al.  The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target , 2020, International journal of molecular sciences.

[17]  Zebao He,et al.  Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.

[18]  Hong Wang,et al.  Plasma metabolomic and lipidomic alterations associated with COVID-19 , 2020, medRxiv.

[19]  H. K. Kotapati,et al.  Normal phase HPLC method for combined separation of both polar and neutral lipid classes with application to lipid metabolic flux. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Chao Zhang,et al.  Liver injury in COVID-19: management and challenges , 2020, The Lancet Gastroenterology & Hepatology.

[21]  M. Zeller,et al.  Evaluation of Lipid In-Source Fragmentation on Different Orbitrap-based Mass Spectrometers. , 2019, Journal of the American Society for Mass Spectrometry.

[22]  F. Violi,et al.  Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? , 2019, World journal of gastroenterology.

[23]  Christer S. Ejsing,et al.  Lipidomics needs more standardization , 2019, Nature Metabolism.

[24]  John A. Bowden,et al.  Optimization of Electrospray Ionization Source Parameters for Lipidomics To Reduce Misannotation of In-Source Fragments as Precursor Ions. , 2018, Analytical chemistry.

[25]  Matej Oresic,et al.  Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950–Metabolites in Frozen Human Plasma[S] , 2017, Journal of Lipid Research.

[26]  G. Shui,et al.  Lipidomics, en route to accurate quantitation. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[27]  M. Del Poeta,et al.  Sphingolipidomics: An Important Mechanistic Tool for Studying Fungal Pathogens , 2016, Front. Microbiol..

[28]  Y. Feng,et al.  Fragmentation patterns of five types of phospholipids by ultra-high-performance liquid chromatography electrospray ionization quadrupole time-of-flight tandem mass spectrometry , 2016 .

[29]  Huanjie Shao,et al.  Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells1 , 2015, Neoplasia.

[30]  B. Melichar,et al.  Lipidomic differentiation between human kidney tumors and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[31]  S. Kohlwein,et al.  A versatile ultra-high performance LC-MS method for lipid profiling , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[32]  Ursula Loizides-Mangold.  On the future of mass‐spectrometry‐based lipidomics , 2013, The FEBS journal.

[33]  Xianlin Han,et al.  Accurate Quantification of Lipid Species by Electrospray Ionization Mass Spectrometry — Meets a Key Challenge in Lipidomics , 2011, Metabolites.

[34]  B. Buszewski,et al.  Hydrophilic interaction liquid chromatography (HILIC)—a powerful separation technique , 2011, Analytical and Bioanalytical Chemistry.

[35]  Markus R Wenk,et al.  Lipidomics: New Tools and Applications , 2010, Cell.

[36]  T. Hankemeier,et al.  RPLC-ion-trap-FTMS method for lipid profiling of plasma: method validation and application to p53 mutant mouse model. , 2008, Journal of proteome research.

[37]  A. Shevchenko,et al.  Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.

[38]  J. Nicholson,et al.  Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics. , 2007, Journal of proteome research.

[39]  J. Hawthorne,et al.  Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.

[40]  K. Hostetler,et al.  Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. , 1985, The Journal of biological chemistry.

[41]  F. B. Jungalwala,et al.  Reversed-phase high performance liquid chromatography of phosphatidylcholine: a simple method for determining relative hydrophobic interaction of various molecular species. , 1981, Journal of lipid research.

[42]  P. Gérard.  The crosstalk between the gut microbiota and lipids , 2020, OCL.

[43]  M. Holčapek,et al.  Lipidomic Analysis. , 2018, Analytical chemistry.

[44]  Xianlin Han,et al.  Lipidomics in diabetes and the metabolic syndrome. , 2007, Methods in enzymology.